{"schema_version":"secwatch.filing_event.v1","accession":"0001764046-26-000117","form_type":"8-K","ticker":"CLVT","cik":"0001764046","company_name":"CLARIVATE PLC","filed_at":"2026-10-06T20:29:39+00:00","discovered_at":"2026-10-06T20:31:01.532943+00:00","generated_at":"2026-10-12T16:14:54.289873+00:00","sec_items":["2.01","5.02","8.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Clarivate closes $600M sale of Life Sciences & Healthcare to Altaris; segment head Levy departs","bullets":["Deal consideration: $500M cash at closing plus a $75M unsecured senior note from an Altaris affiliate and $25M deferred cash payable by January 31, 2028.","Henry Levy, President, Life Sciences & Healthcare, terminated employment at closing; separation agreement follows the retention agreement disclosed July 6, 2026.","Clarivate will use proceeds to reduce debt; remaining portfolio is Academia & Government (Web of Science, ProQuest, Alma, Vega) and Intellectual Property (IPOne, Derwent, CompuMark, IPfolio).","Q3 2026 results are set for November 3, 2026, when Clarivate will update full-year 2026 guidance to reflect the divestiture.","Pro forma condensed balance sheet as of June 30, 2026 and statements of operations for 2023-2025 and 1H26 to be filed by October 13, 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001764046-26-000117","json":"https://secwatch.observer/filing/0001764046-26-000117.json","markdown":"https://secwatch.observer/filing/0001764046-26-000117.md","text":"https://secwatch.observer/filing/0001764046-26-000117.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1764046/000176404626000117/0001764046-26-000117-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1764046/000176404626000117/clvt-20261006.htm"},"model":{"generated_by":"deepseek-v4.1-flash:cloud@v2","generated_at":"2026-10-12T16:14:54.289873+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"07ecdabd9b","claim":"Henry Levy departed as President, Life Sciences & Healthcare at CLARIVATE PLC.","evidence_excerpt":"Upon the Closing and in connection with the Transaction, Henry Levy, Clarivate’s President, Life Sciences & Healthcare, terminated employment with a subsidiary of Clarivate.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1764046/000176404626000117/0001764046-26-000117-index.htm","confidence":0.9,"family_label":"Executive change","details":[{"label":"Action","value":"terminated employment"},{"label":"Role","value":"President, Life Sciences & Healthcare"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}